Regeneron Pharmaceuticals, Inc. (REGN)
753.89
-1.62
(-0.21%)
USD |
NASDAQ |
Apr 15, 16:00
753.78
-0.11
(-0.01%)
After-Hours: 20:00
Regeneron Pharmaceuticals Market Cap : 79.70B for April 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 187.68B |
| Eli Lilly & Co. | 810.27B |
| Merck & Co., Inc. | 291.45B |
| Pfizer Inc. | 154.64B |
| AbbVie, Inc. | 368.54B |
Market Cap Related Metrics
| PE Ratio | 18.14 |
| PS Ratio | 5.710 |
| PEG Ratio | 2.119 |
| Price to Book Value | 2.550 |
| Price to Free Cash Flow | 21.75 |
| Price | 753.89 |
| Earnings Yield | 5.51% |
| PEGY Ratio | 2.008 |
| Operating PE Ratio | 22.12 |
| Normalized PE Ratio | 18.52 |